Results 231 to 240 of about 206,934 (330)

Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3. [PDF]

Pathol Oncol Res
Szalóki G, Szepesi Á, Tárkányi I, Márk Á, Kriston C, Hunyadi A, Mózes R, Barna G.   +7 more
europepmc   +1 more source

Retrospective analysis of non‐anaplastic peripheral T‐cell lymphoma in pediatric patients in Japan [PDF]

, 2009
Ryōji Kobayashi, Kazumi Yamato, Fumiko Tanaka, Yoshifumi Takashima, Hiroko Inada, Akira Kikuchi, Masaaki Kumagai, Shosuke Sunami, Atsuko Nakagawa, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Masahito Tsurusawa, Tetsuya Mori   +13 more
openalex   +1 more source

A comprehensive review on adaptive plasticity and recovery mechanisms post‐acquired brain injury

Neuroprotection, EarlyView.
This figure illustrates the dynamic process of neurogenesis following brain injury, focusing on the roles of neural stem and progenitor cells at the injury site. Key mechanisms include axonal sprouting, synaptogenesis, dendritic remodeling, and brain‐derived neurotrophic factor signaling via TrkB receptors.
Ravi Kumar Rajan
wiley   +1 more source

Rare primary gastric peripheral T-cell lymphoma not otherwise specified: A case report. [PDF]

World J Clin Cases
Jang HR, Lee K, Lim KH.
europepmc   +1 more source

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project [PDF]

, 2009
Junji Suzumiya, K Ohshima, Kazuo Tamura, Kennosuke Karube, Naokuni Uike, Kensei Tobinai, Randy D. Gascoyne, Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger   +9 more
openalex   +1 more source

Lymphoid Malignancies in Ataxia–Telangiectasia: Experience with Novel Targeted Therapies

Pediatric Blood &Cancer, Volume 72, Issue 9, September 2025.
ABSTRACT Patients with ataxia–telangiectasia (AT) face unique challenges in managing lymphoid malignancies due to heightened sensitivity to chemotherapy and radiation, requiring alternative treatment strategies. This report presents three cases demonstrating the successful integration of targeted therapies: ibrutinib for diffuse large B‐cell lymphoma ...
Samanta Catueno, Ramya Ramakrishnan, Sarah Elitzur, Miriam B. Garcia, David McCall, Cesar Nunez, Michael Roth, Alessandra Ferrajoli, Branko Cuglievan, Amber Gibson   +9 more
wiley   +1 more source

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma. [PDF]

Bone Marrow Transplant
Krämer I, König L, Luft T, Hegenbart U, Schönland S, Eichkorn T, Stadtherr P, Selberg L, Müller-Tidow C, Dreger P.   +9 more
europepmc   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Two Atypical Clinical Cases of a Rare Lymphoma: Peripheral T-Cell Lymphoma. [PDF]

Cureus
Araújo SG, Vale MM, Araújo IM, Azevedo R, Oliveira A.   +4 more
europepmc   +1 more source

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience

, 2007
José Rodríguez, E. Condé, Antonio Gutiérrez, R. Arranz, Agathe León, J. Marín, Maurizio Bendandi, Carmen Albó, Marı́a Dolores Caballero   +8 more
openalex   +1 more source